Predictors of Brain Tumor-Associated Epilepsy: A Retrospective Cohort Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037942

Enrollment

10000

Registered

2025-09-22

Start date

2026-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICD-10 codes C71.- and C72.- (primary CNS tumors), as well as C79.3 and C79.4 (secondary CNS tumors) C71 C72 C79.3 C79.4

Interventions

Group 1: All patients treated at the Department of Neurology at Heidelberg University Hospital with a tumor of the central nervous system (CNS), for whom data are available between January 1, 2000, an

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: None

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Occurrence of at least one unprovoked epileptic seizure during the course of the brain tumor disease (dichotomous variable: yes / no)	—

Secondary

Measure	Time frame
- Time of first epileptic seizure (if documented; for time-to-event analyses) - Type of first seizure (focal / generalized; further classification if applicable) - Association between clinical, imaging, and molecular pathological parameters and seizure risk	—

Countries

Germany

Contacts

Public ContactTobias Kessler

Neurologische Klinik, Universitätsklinikum Heidelberg

neurologie@med.uni-heidelberg.de06221 56 6999

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026